Remy B Verheijen Selected Research

Remy B Verheijen Research Topics

12	Neoplasms (Cancer) 01/2022 - 04/2014
7	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 01/2016
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2016
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
3	Disease Progression 01/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2017
1	Stomatitis 01/2022
1	Chemical and Drug Induced Liver Injury 01/2021
1	Vomiting 01/2021
1	Nausea 01/2021
1	Hypersensitivity (Allergy) 10/2020
1	Anaphylaxis (Anaphylactic Shock) 10/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Kidney Neoplasms (Kidney Cancer) 01/2018
1	Hypertension (High Blood Pressure) 01/2017

7	pazopanib FDA Link 11/2021 - 01/2016
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 12/2016
5	1- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA 01/2021 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2021
2	Everolimus FDA Link 01/2022 - 01/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2021
2	osimertinibIBA 01/2021 - 01/2020
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019 - 01/2019
2	ElacridarIBA 01/2018 - 01/2017
1	Circulating Tumor DNAIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	Investigational DrugsIBA 10/2020
1	Sunitinib (Sutent)FDA Link 01/2020
1	Angiogenesis InhibitorsIBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 04/2014
1	PRS-110IBA 04/2014

2	Therapeutics 01/2021 - 03/2019
1	Radiotherapy 11/2021